Washington: In a breakthrough, an Indian-American scientist at the prestigious Massachusetts Institute of Technology (MIT) has developed a simple, cheap, paper test that could improve cancer diagnosis rates and help people get treated earlier.
The diagnostic, which works much like a pregnancy test, could reveal within minutes, based on a urine sample, whether a person has cancer, the Massachusetts Institute of Technology (MIT) announced yesterday.
This approach has helped detect infectious diseases, and the new technology allows non-communicable diseases to be detected using the same strategy, it said.
The technology, developed by MIT professor and Howard Hughes Medical Institute investigator 46-year-old Sangeeta Bhatia, relies on nanoparticles that interact with tumour proteins called proteases, each of which can trigger release of hundreds of biomarkers that are then easily detectable in a patient's urine.
"When we invented this new class of synthetic biomarker, we used a highly specialised instrument to do the analysis," says Mrs Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science.
"For the developing world, we thought it would be exciting to adapt it instead to a paper test that could be performed on unprocessed samples in a rural setting, without the need for any specialized equipment. The simple readout could even be transmitted to a remote caregiver by a picture on a mobile phone," Mrs Bhatia said in a statement.
Mrs Bhatia, a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science, is the senior author of a paper describing the particles in the Proceedings of the National Academy of Sciences published this week.
The paper's lead authors are graduate student Andrew Warren, postdoc Gabriel Kwong, and former postdoc David Wood.
The diagnostic, which works much like a pregnancy test, could reveal within minutes, based on a urine sample, whether a person has cancer, the Massachusetts Institute of Technology (MIT) announced yesterday.
This approach has helped detect infectious diseases, and the new technology allows non-communicable diseases to be detected using the same strategy, it said.
"When we invented this new class of synthetic biomarker, we used a highly specialised instrument to do the analysis," says Mrs Bhatia, the John and Dorothy Wilson Professor of Health Sciences and Technology and Electrical Engineering and Computer Science.
Advertisement
Mrs Bhatia, a member of MIT's Koch Institute for Integrative Cancer Research and Institute for Medical Engineering and Science, is the senior author of a paper describing the particles in the Proceedings of the National Academy of Sciences published this week.
Advertisement
COMMENTS
- Massachusetts Institute of Technology
- infectious diseases
- Sangeeta Bhatia
- cancer
- scientist
- Professor of Health Sciences
- tumour
- non-communicable diseases
- National Academy of Sciences
- David Wood
- MIT's Koch Institute for Integrative Cancer Research
- Institute for Medical Engineering and Science
- Andrew Warren
- Gabriel Kwong
Advertisement
Hina Khan, Battling Cancer, Shares Pic From Hospital: "Constantly In Pain" Hina Khan Resumes Work After Cancer Diagnosis. Tara Sutaria, Kusha Kapila And Other Celebs Form Her Cheer Squad US Scientists Decode 125-Year-Old Element That Could Improve Cancer Treatments World's Largest Isolated Tribe Makes Rare Appearance In New Footage At Least 2 Passengers Die As Chandigarh-Dibrugarh Express Derails In UP Puja Khedkar's Mother Was Hiding At Lodge With Cab Driver, Used Fake ID Britain Failed By Flawed Planning For Coronavirus Pandemic, Probe Finds Malavika Mohanan's Pastel Saree Perfectly Matched Her Charming Elegance Chartered Accountancy Final Exam Schedule For November Session Out Track Latest News Live on NDTV.com and get news updates from India and around the world.